Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5821 to 5835 of 7677 results

  1. Training:- What are the effects of different approaches to home care training on outcomes for people who use home care services?

    Recommendation ID NG21/3 Question Training:- What are the effects of different approaches to home care training on outcomes for people

    Research recommendation
    Published
    13 October 2015

  2. Evidence on the safety of transcranial magnetic stimulation for auditory hallucinations is adequate and raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. Find out  what only in research means on the NICE interventional procedures guidance page . Further research should be in the form of randomised controlled trials and should use well described treatment protocols. Studies should report details of patient selection including specific psychopathology, underlying disease and other treatments, the area of brain treated and the imaging used to target it, and long-term outcomes for at least 1 year.

    Recommendation ID IPG680 Question Evidence on the safety of transcranial magnetic stimulation for auditory hallucinations is adequate

    Research recommendation
    Published
    26 October 2020

  3. Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises no major safety concerns. However, evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research.  Find out  what only in research means on the NICE website .

    Recommendation ID IPG676 Question Evidence on the safety of transcranial magnetic stimulation for obsessive-compulsive disorder raises

    Research recommendation
    Published
    10 August 2020

  4. Transition in special groups: looked-after young people:- What is the most effective way of supporting care leavers in transition from children's to adults' health services?

    Recommendation ID NG43/8 Question Transition in special groups: looked-after young people:- What is the most effective way of supporting

    Research recommendation
    Published
    21 March 2016

  5. Transition in special groups: young offenders institutions:- What is the most effective way of supporting young offenders in transition from children's to adults' health and social care services?

    Recommendation ID NG43/7 Question Transition in special groups: young offenders institutions:- What is the most effective way of supporting

    Research recommendation
    Published
    21 March 2016

  6. Transition support for young adults:- What approaches to providing transition support for those who move from child to adult services are effective and/or cost-effective?

    Recommendation ID NG43/1 Question Transition support for young adults:- What approaches to providing transition support for those who move

    Research recommendation
    Published
    21 March 2016

  7. Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a transjugular intrahepatic portosystemic shunt (TIPS)?

    Recommendation ID NG50/7 Question Transjugular intrahepatic portosystemic shunt:- What is the quality of life in people who have had a

    Research recommendation
    Published
    11 January 2024

  8. The evidence on the safety of transurethral laser ablation for recurrent non-muscle-invasive bladder cancer shows that there are no major safety concerns. However, current evidence on its efficacy is limited in quality and quantity. Therefore, this procedure should only be used with  special arrangements   for clinical governance, consent, and audit or research.

    Recommendation ID IPG656/1 Question The evidence on the safety of transurethral laser ablation for recurrent non-muscle-invasive bladder

    Research recommendation
    Published
    15 November 2019

  9. Treating an eating disorder in people with a comorbidity:- What is the impact of comorbidities on treatment outcomes for eating disorders, and whatapproaches are effective in managing these comorbidities?

    Recommendation ID NG69/4 Question Treating an eating disorder in people with a comorbidity:- What is the impact of comorbidities on treatment

    Research recommendation
    Published
    12 October 2018

  10. For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?

    Recommendation ID NG33/3 Question For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?

    Research recommendation
    Published
    8 November 2019

  11. Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and prevent first variceal bleeds in people with cirrhosis that is associated with small oesophageal varices?

    Recommendation ID NG50/2 Question Treating small oesophageal varices:- Do non-selective beta-blockers improve survival and prevent first

    Research recommendation
    Published
    25 August 2016

  12. What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy compared to resection for people with metastatic colorectal cancer in the lung amenable to local treatment?

    Recommendation ID NG151/1 Question What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy

    Research recommendation
    Published
    10 February 2020

  13. Treatment for people with an IOP of 22 or 23 mmHg:- What is the clinical and cost effectiveness of treating an intraocular pressure (IOP) of 22 or 23 mmHg in people with normal optic discs and visual fields?

    Recommendation ID NG81/6 Question Treatment for people with an IOP of 22 or 23 mmHg:- What is the clinical and cost effectiveness of treating

    Research recommendation
    Published
    1 February 2022

  14. For people with active, drug susceptible TB who experience treatment interruptions because of adverse events, particularly hepatotoxicity, what approach to re-establishing treatment is mosteffective in reducing mortality and morbidity?

    Recommendation ID NG33/5 Question For people with active, drug susceptible TB who experience treatment interruptions because of adverse

    Research recommendation
    Published
    8 November 2019

  15. Treatment of convulsive status epilepticus (that is, not just refractory): What is the most effective and safest AED to treat: established (usually lasting longer than 30 minutes) convulsive status epilepticus refractory convulsive status epilepticus?

    Recommendation ID CG137/4 Question Treatment of convulsive status epilepticus (that is, not just refractory): What is the most effective

    Research recommendation
    Published
    13 August 2021